^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TSC-101

    i
    Associations
    News

    Trials

    Company:
    TSCan Therap
    Drug class:
    TCR modulator
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Study of TSC-100 and TSC-101 in AML, ALL and MDS Patients Undergoing Haploidentical Donor Transplantation (TSCAN-001) (NCT05473910)
    Phase 1
    TScan Therapeutics, Inc.
    Recruiting
    Last update posted :
    06/13/2024
    Initiation :
    11/01/2022
    Primary completion :
    12/01/2024
    Completion :
    06/01/2025
    HLA-A
    |
    HLA-A*02 • HLA-A2 positive • HLA-A positive
    |
    melphalan • TSC-100 • TSC-101